CJC-1295 (Modified GRF 1-29)
CJC-1295 without DAC (also called Modified GRF 1-29) is a synthetic growth hormone-releasing compound with a short active window of about 30 minutes. It is being studied for its effects on growth hormone release and body composition.
A leading innovator in research chemicals.
|Exclusive OfferUse our affiliate link and code PEPTIDEWIKI at checkout to unlock your 10% discount, every time you use the code.
Shop NowFor research purposes only. PeptideWiki may earn a commission at no extra cost to you.
CJC-1295 (Modified GRF 1-29)
For research purposes only. PeptideWiki may earn a commission at no extra cost to you.
Overview of CJC-1295 (Modified GRF 1-29)
Stimulates growth hormone release by activating GHRH receptors on pituitary cells, leading to elevated IGF-1 and anabolic effects.
Binds to GHRH receptors on pituitary somatotroph cells, triggering signaling cascades that promote GH synthesis and release.
Stimulates pulsatile GH secretion, leading to 2-10x elevation in circulating growth hormone levels.
Increases hepatic IGF-1 production, mediating anabolic effects on muscle, bone, and connective tissue.
With DAC (Drug Affinity Complex): Contains lysine linker binding albumin, extending half-life to several days for sustained GH elevation.
Without DAC (Mod GRF 1-29): Shorter half-life (~30 minutes), which may better preserve natural pulsatile GH release patterns.
Often combined with ghrelin mimetics like Ipamorelin (proposed), amplifying GH release through complementary receptor pathways
Read Full CJC-1295 (Modified GRF 1-29) Dosage Guide
Research-backed dosing protocols, timing, and administration details
Browse more in this category
Growth Hormone / IGF-1 Axis
CJC-1295 vs CJC-1295 with DAC: Which One Fits Your Goals?
Two versions of the same peptide, completely different experiences. Here is how to decide which CJC-1295 variant actually fits your lifestyle and goals.
Peptide Therapy for Sleep Optimization: The Quiet Trend Reshaping Recovery in 2026
Peptide therapy is quietly becoming the most promising frontier in sleep science. From DSIP to growth hormone secretagogues, here's how peptides are being studied for deep sleep and recovery.
RFK Jr. Says 14 Peptides Are Coming Back: Ban Reversal
HHS Secretary RFK Jr. told Joe Rogan that ~14 peptides banned by the FDA in 2023 will return to Category 1, restoring legal compounding access.
TB-500 vs BPC-157: Differences, Benefits, and Which One to Choose
TB-500 and BPC-157 are the two most popular healing peptides — but they work through completely different mechanisms. Here's how they compare, when to use each, and whether stacking them makes sense.